Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Modern Diagnostic & Research Centre PS Ratio?
Modern Diagnostic & Research CentreBOM:544673 +8.76%17 PS Ratio is 2.50 as of Sep. 11, 2026, which is 112% above its 10-year median of 1.18. GuruFocus rates BOM:544673 with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 200 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks better than 54.5% on this metric.
BOM:544673's PS Ratio is ranked better than 54.5% of 200
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.815
vs BOM:544673: 2.50
Modern Diagnostic & Research Centre (BOM:544673) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Modern Diagnostic & Research Centre PS Ratio Related Terms
Modern Diagnostic & Research Centre PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre PS Ratio Chart
Modern Diagnostic & Research Centre Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
0.97
Modern Diagnostic & Research Centre Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
PS Ratio
0.00
0.00
0.00
0.97
BOM:544673 vs TMO, DHR, NTRA: PS Ratio Comparison
For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Diagnostic & Research Centre PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's PS Ratio distribution charts can be found below:
* The bar in red indicates where Modern Diagnostic & Research Centre's PS Ratio falls into.
Modern Diagnostic & Research Centre PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Modern Diagnostic & Research Centre's Share Price of today is ₹66.17.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Modern Diagnostic & Research Centre's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹26.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Modern Diagnostic & Research Centre (BOM:544673) has a PS Ratio of 2.50 as of Sep. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Modern Diagnostic & Research Centre and its competitors. This is 112% above median its historical median of 1.18. Over the past decade, Modern Diagnostic & Research Centre's PS Ratio has ranged from 0.89 to 2.50. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #91 out of 200 companies in the Medical Diagnostics & Research industry, placing it in the top 45.5%.
Is Modern Diagnostic & Research Centre's PS Ratio too high?
Modern Diagnostic & Research Centre's current PS Ratio of 2.50 is 112% above median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.89 to a high of 2.50. The Medical Diagnostics & Research industry median PS Ratio is 2.82. Modern Diagnostic & Research Centre's value of 2.50 is 11.2% below this industry median. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #91 out of 200 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #91 out of 200 companies for PS Ratio. This puts Modern Diagnostic & Research Centre in the upper half of its industry. The industry median PS Ratio is 2.82. Modern Diagnostic & Research Centre's value of 2.50 is 11.2% below this benchmark. Historically, Modern Diagnostic & Research Centre's own PS Ratio has ranged from 0.89 to 2.50 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 2.82, Modern Diagnostic & Research Centre has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.82, based on 200 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Modern Diagnostic & Research Centre's current PS Ratio of 2.50 is 11.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Modern Diagnostic & Research Centre and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Modern Diagnostic & Research Centre's current PS Ratio is 2.50, which is 112% above median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current PS Ratio of 2.50. The current PS Ratio is 2.50, which is 112% above median its 10-year median of 1.18 and 11.2% below the Medical Diagnostics & Research industry median of 2.82. Modern Diagnostic & Research Centre's overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current PS Ratio is 2.50 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
17GF Score
Get the complete analysis for BOM:544673
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544673 has been successfully added to your 
